Tag: rapid aging disease
Progeria
The first drug to treat Hutchinson-Gilford Progeria, a rare and uniformly fatal rapid aging disease, has been approved by the FDA. It can prolong the life of these children by 2.5 years, but it is very expensive.
Exploring issues and controversies in the relationship between science and medicine
The first drug to treat Hutchinson-Gilford Progeria, a rare and uniformly fatal rapid aging disease, has been approved by the FDA. It can prolong the life of these children by 2.5 years, but it is very expensive.